PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1535559
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1535559
Facial Injectables Market Size - By Product (Collagen, PMMA Microspheres, Hyaluronic Acid, Botulinum Toxin, Calcium Hydroxylapatite, Poly-L-lactic Acid), Application (Wrinkle Reduction, Facial Line Correction, Face Lift), End-use & Forecast, 2024 - 2032
Facial Injectables Market size is projected to record 10.3% CAGR from 2024 to 2032, driven by ongoing technological advancements in imaging and injection techniques.
Numerous companies are working on improving imaging technologies to provide more precise and accurate assessments of facial anatomy for enhancing the effectiveness and safety of injectables. Innovations in injection techniques are also minimizing discomfort and maximizing results with developments for refining needle designs and injection methods for better outcomes. For instance, in July 2024, Juvederm received the U.S. FDA approval for Juvederm Skinvive, its first micro droplet facial injectable designed to provide a more refined and natural-looking enhancement for improved results.
The overall market is segregated into product, application, end-use, and region.
In terms of product, the fat injection devices segment in the facial injectables market will experience significant growth by 2032, due to increasing demand for natural and long-lasting enhancements. Of late, there have been rising efforts on improving techniques for fat extraction, purification, and injection to achieve optimal results. Innovations are also refining the methods used in integrating the fat smoothly into facial tissues for ensuring better contouring and volume restoration.
By application, the facial injectables industry share from the lip augmentation segment is projected to grow at a notable CAGR from 2024 to 2032, driven by increasing consumer preference for enhanced lip volume and contour. Advancements are refining the injectables used for this purpose with improvements in formulations to provide more natural and longer-lasting results. Innovations in injection techniques are also helping in achieving precise and symmetrical outcomes while minimizing discomfort and downtime for patients.
Regionally, the Asia Pacific facial injectables market size is predicted to exhibit lucrative growth between 2024 and 2032, fueled by the influence of celebrities and increased media exposure, alongside rising disposable incomes. Media coverage and celebrity endorsements in the region are driving the interest and acceptance of facial injectables, making them more prominent in popular culture. The ongoing improvements in both product offerings and accessibility will also support the sustained growth and integration of facial injectables into mainstream beauty and wellness routines.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Growing geriatric population
- 3.2.1.2 Technological advancements in facial injectables
- 3.2.1.3 Increasing awareness and acceptance of aesthetic treatments
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Stringent regulatory scenario
- 3.2.2.2 Risk of adverse reactions
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Technological landscape
- 3.5 Regulatory landscape
- 3.6 Pricing analysis, 2023
- 3.6.1 By region
- 3.6.2 By key player
- 3.7 Future market trends
- 3.8 Porter's analysis
- 3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.3 Company matrix analysis
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Collagen
- 5.3 Poly methyl methacrylate (PMMA) microspheres
- 5.4 Hyaluronic acid (HA)
- 5.5 Botulinum toxin
- 5.6 Calcium hydroxylapatite (CaHA)
- 5.7 Poly-L-lactic acid (PLLA)
- 5.8 Fat injection
- 5.9 Other products
Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Wrinkle reduction
- 6.3 Facial line correction
- 6.4 Lip augmentation
- 6.5 Face lift
- 6.6 Acne scar treatment
- 6.7 Lipoatrophy treatment
- 6.8 Other applications
Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Medical spas
- 7.3 Dermatology clinics
- 7.4 Hospitals
- 7.5 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
- 8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
- 9.1 AbbVie Inc.
- 9.2 Anika Therapeutics, Inc.
- 9.3 APAX Partners
- 9.4 Bioplus Co., Ltd.
- 9.5 Croma-Pharma GmbH
- 9.6 Galderma SA
- 9.7 Ipsen Pharma
- 9.8 Lutronic Corporation
- 9.9 Medytox
- 9.10 Merz Pharma
- 9.11 Prollenium Medical Technologies
- 9.12 Revance Therapeutics, Inc.
- 9.13 Sinclair
- 9.14 Suneva Medical
- 9.15 Teoxane
